vs
Innoviva, Inc.（INVA）与Rapid7, Inc.（RPD）财务数据对比。点击上方公司名可切换其他公司
Rapid7, Inc.的季度营收约是Innoviva, Inc.的1.9倍（$217.4M vs $114.6M），Innoviva, Inc.净利率更高（143.2% vs 1.4%，领先141.8%），Innoviva, Inc.同比增速更快（24.8% vs 0.5%），过去两年Innoviva, Inc.的营收复合增速更高（21.6% vs 3.0%）
Innoviva Inc是一家专注于呼吸道疾病、传染病及重症护理领域处方治疗药物研发、商业化及特许权使用费管理的医疗保健企业，与全球领先制药商合作，为北美、欧洲等核心市场的患者提供哮喘、慢性阻塞性肺疾病等病症的治疗方案。
Rapid7是全球领先的网络安全企业，提供漏洞管理、威胁检测与响应、云安全、安全分析等全系列安全解决方案，服务全球科技、医疗、金融、制造等行业的各类规模企业及公共部门客户，助力客户高效识别、应对和缓解网络安全风险。
INVA vs RPD — 直观对比
营收规模更大
RPD
是对方的1.9倍
$114.6M
营收增速更快
INVA
高出24.3%
0.5%
净利率更高
INVA
高出141.8%
1.4%
两年增速更快
INVA
近两年复合增速
3.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $114.6M | $217.4M |
| 净利润 | $164.2M | $3.1M |
| 毛利率 | 66.0% | 68.9% |
| 营业利润率 | 34.0% | 1.0% |
| 净利率 | 143.2% | 1.4% |
| 营收同比 | 24.8% | 0.5% |
| 净利润同比 | 707.4% | 44.1% |
| 每股收益（稀释后） | $2.19 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INVARPD
| Q4 25 | $114.6M | $217.4M | ||
| Q3 25 | $107.8M | $218.0M | ||
| Q2 25 | $100.3M | $214.2M | ||
| Q1 25 | $88.6M | $210.3M | ||
| Q4 24 | $91.8M | $216.3M | ||
| Q3 24 | $89.5M | $214.7M | ||
| Q2 24 | $99.9M | $208.0M | ||
| Q1 24 | $77.5M | $205.1M |
净利润INVARPD
| Q4 25 | $164.2M | $3.1M | ||
| Q3 25 | $89.9M | $9.8M | ||
| Q2 25 | $63.7M | $8.3M | ||
| Q1 25 | $-46.6M | $2.1M | ||
| Q4 24 | $20.3M | $2.2M | ||
| Q3 24 | $1.2M | $15.4M | ||
| Q2 24 | $-34.7M | $6.5M | ||
| Q1 24 | $36.5M | $1.4M |
毛利率INVARPD
| Q4 25 | 66.0% | 68.9% | ||
| Q3 25 | 70.1% | 70.2% | ||
| Q2 25 | 82.9% | 70.6% | ||
| Q1 25 | 82.7% | 71.7% | ||
| Q4 24 | 85.1% | 69.5% | ||
| Q3 24 | 81.6% | 70.6% | ||
| Q2 24 | 85.1% | 70.7% | ||
| Q1 24 | 77.5% | 70.3% |
营业利润率INVARPD
| Q4 25 | 34.0% | 1.0% | ||
| Q3 25 | 32.1% | 2.7% | ||
| Q2 25 | 48.6% | 1.6% | ||
| Q1 25 | 46.7% | -0.0% | ||
| Q4 24 | 47.0% | 3.4% | ||
| Q3 24 | 48.3% | 6.0% | ||
| Q2 24 | 54.7% | 2.5% | ||
| Q1 24 | 33.3% | 4.7% |
净利率INVARPD
| Q4 25 | 143.2% | 1.4% | ||
| Q3 25 | 83.4% | 4.5% | ||
| Q2 25 | 63.5% | 3.9% | ||
| Q1 25 | -52.6% | 1.0% | ||
| Q4 24 | 22.1% | 1.0% | ||
| Q3 24 | 1.4% | 7.2% | ||
| Q2 24 | -34.7% | 3.1% | ||
| Q1 24 | 47.1% | 0.7% |
每股收益（稀释后）INVARPD
| Q4 25 | $2.19 | $0.05 | ||
| Q3 25 | $1.08 | $0.15 | ||
| Q2 25 | $0.77 | $0.13 | ||
| Q1 25 | $-0.74 | $0.03 | ||
| Q4 24 | $0.43 | $0.08 | ||
| Q3 24 | $0.02 | $0.21 | ||
| Q2 24 | $-0.55 | $0.09 | ||
| Q1 24 | $0.46 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $550.9M | $474.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.2B | $154.7M |
| 总资产 | $1.6B | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资INVARPD
| Q4 25 | $550.9M | $474.7M | ||
| Q3 25 | $476.5M | $407.1M | ||
| Q2 25 | $397.5M | $511.7M | ||
| Q1 25 | $319.1M | $493.5M | ||
| Q4 24 | $305.0M | $521.7M | ||
| Q3 24 | $260.6M | $443.7M | ||
| Q2 24 | $217.0M | $442.6M | ||
| Q1 24 | $178.4M | $411.7M |
股东权益INVARPD
| Q4 25 | $1.2B | $154.7M | ||
| Q3 25 | $1.0B | $127.2M | ||
| Q2 25 | $714.8M | $90.4M | ||
| Q1 25 | $646.9M | $52.7M | ||
| Q4 24 | $691.2M | $17.7M | ||
| Q3 24 | $668.5M | $-5.1M | ||
| Q2 24 | $665.5M | $-52.6M | ||
| Q1 24 | $703.7M | $-86.4M |
总资产INVARPD
| Q4 25 | $1.6B | $1.7B | ||
| Q3 25 | $1.4B | $1.7B | ||
| Q2 25 | $1.3B | $1.6B | ||
| Q1 25 | $1.3B | $1.6B | ||
| Q4 24 | $1.3B | $1.7B | ||
| Q3 24 | $1.2B | $1.6B | ||
| Q2 24 | $1.2B | $1.5B | ||
| Q1 24 | $1.3B | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $54.5M | $37.6M |
| 自由现金流经营现金流 - 资本支出 | — | $36.4M |
| 自由现金流率自由现金流/营收 | — | 16.8% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | 0.33× | 12.01× |
| 过去12个月自由现金流最近4个季度 | — | $146.2M |
8季度趋势，按日历期对齐
经营现金流INVARPD
| Q4 25 | $54.5M | $37.6M | ||
| Q3 25 | $49.7M | $39.0M | ||
| Q2 25 | $44.1M | $47.5M | ||
| Q1 25 | $48.6M | $29.8M | ||
| Q4 24 | $59.2M | $63.8M | ||
| Q3 24 | $48.7M | $44.0M | ||
| Q2 24 | $43.7M | $32.9M | ||
| Q1 24 | $37.0M | $31.1M |
自由现金流INVARPD
| Q4 25 | — | $36.4M | ||
| Q3 25 | — | $34.8M | ||
| Q2 25 | — | $46.6M | ||
| Q1 25 | — | $28.4M | ||
| Q4 24 | — | $62.6M | ||
| Q3 24 | $48.4M | $42.6M | ||
| Q2 24 | — | $32.6M | ||
| Q1 24 | — | $30.4M |
自由现金流率INVARPD
| Q4 25 | — | 16.8% | ||
| Q3 25 | — | 16.0% | ||
| Q2 25 | — | 21.8% | ||
| Q1 25 | — | 13.5% | ||
| Q4 24 | — | 28.9% | ||
| Q3 24 | 54.1% | 19.9% | ||
| Q2 24 | — | 15.7% | ||
| Q1 24 | — | 14.8% |
资本支出强度INVARPD
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | 0.0% | 0.5% | ||
| Q3 24 | 0.3% | 0.6% | ||
| Q2 24 | 0.0% | 0.1% | ||
| Q1 24 | 0.0% | 0.3% |
现金转化率INVARPD
| Q4 25 | 0.33× | 12.01× | ||
| Q3 25 | 0.55× | 3.97× | ||
| Q2 25 | 0.69× | 5.70× | ||
| Q1 25 | — | 14.14× | ||
| Q4 24 | 2.91× | 29.36× | ||
| Q3 24 | 40.14× | 2.85× | ||
| Q2 24 | — | 5.03× | ||
| Q1 24 | 1.01× | 22.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INVA
| Royalty | $54.9M | 48% |
| Xacduro | $32.1M | 28% |
| Giapreza | $19.6M | 17% |
| Xerava | $7.3M | 6% |
RPD
| Products | $209.1M | 96% |
| Services | $8.2M | 4% |
